CRISPR Therapeutics AG (NASDAQ:CRSP)

98.12
Delayed Data
As of Oct 27
 +3.99 / +4.24%
Today’s Change
32.30
Today|||52-Week Range
111.90
+61.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-25.8M-23.2M-68.4M-165.0M
 
 
 
 
 
Depreciation127.0K925.0K3.0M3.5M
 
 
 
 
 
Total Other Cash Flow3.8M-34.8M20.6M54.7M
 
 
 
 
 
Funds From Operations-21.9M-57.1M-44.7M-106.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-81.4M-1.8M25.4M-10.6M
 
 
 
 
 
Net Cash Flow - Operating Activities59.4M-55.3M-70.1M-96.2M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-100.0K-500.0K0.00
 
 
 
Capital Expenditures-1.2M-3.0M-7.8M-2.8M
 
 
 
 
 
Other Investing - Sources0.0035.0M0.000.00
 
 
Net Cash Flow Investing-1.2M31.9M-8.3M-2.8M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.00-4.0K0.00
 
 
Long Term Borrowings38.2M35.0M0.000.00
 
 
 
Long Term Debt Reduction----0.000.00--
Net Proceeds Stock Sale58.5M148.2M2.6M316.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.00-57.0K
 
 
Common Dividends--0.000.000.00--
Cash Dividends Paid - Total--0.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing96.7M183.2M2.6M315.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash9.0K-235.0K41.0K-22.0K
 
 
 
 
 
 
Net Change In Cash155.0M159.8M-75.8M216.9M